• No se han encontrado resultados

Deregulation of Choline Kinase in Pancreatic Cancer and its inhibition as a potential therapeutic strategy

N/A
N/A
Protected

Academic year: 2020

Share "Deregulation of Choline Kinase in Pancreatic Cancer and its inhibition as a potential therapeutic strategy"

Copied!
158
0
0

Texto completo

Loading

Figure

Figure I1. Anatomy and histology of the pancreas. (A) Cross-sectional diagram showing  the anatomy of the pancreas
Table I1. Risk factors and inherited  cancer syndromes associated with  increased risk of  developing pancreatic cancer
Figure  I2.  PDAC  progression.  (A).  Pancreatic  Ductal  Adenocarcinoma  (PDAC)  linear  progression model according to which ductal cells that acquire KRAS activating mutations  proliferate and form PanIN-1A/B lesions which - due to mutations in tumor s
Figure I3. Pancreatic ductal adenocarcinoma (PDAC): macroscopic and microscopic  aspect
+7

Referencias

Documento similar

In addition, we define a new role for FGFR4 as regulator of the epithelial-mesenchymal transition and invasion in colorectal cancer that makes it an attractive target for

17,18 Contrary to graphene, the band gap in ML-MDS separating the valence and conduction bands is naturally large and due to the absence of inversion symmetry in ML-MDS the

Accordingly, macrophages are the major leukocyte subpopulation present in ADM and PanINs (Clark et al., 2007) and, importantly, it has been shown that in response to

CDK4/6i have been shown to be effective in the pre-clinical treatment of huge variety of solid tumors: breat cancer, hepatoma, glioblastoma, ovarian cancer, neuroblastoma,

Second, hierarchical clustering of pancreatic cancer cell lines with primary tumours enabled the translation of drug sensitivity data from cell lines to the tumour subtypes found

This in turn invites a re-drawing of Giannobile’s catalogue (see below) to allow the possibility that the central elements are in fact the figure appearing on the obverse

In the in vivo animal experiments, Δ 9 -THCA-A successfully show a potential therapeutic effect in inflammatory diseases as we have observed in a model of

(C) lncRNAs can represent a bridge between the many layers of epigenetic gene regulation, interacting with, for example, histone modifiers or serving as ceRNAs for miRNAs; (D)